Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms)
Part I—General Overview

Abstract

The incidence of neuroendocrine tumours of the gastroenteropancreatic system seems to have increased during the past decade. New diagnostic and therapeutic procedures have aroused the interest of physicians, though most see very few cases of such diseases. A group of members of the Nordic Neuroendocrine Tumour Group decided to compile some guidelines to facilitate the diagnosis and treatment of patients with these tumours. Part I of these guidelines discusses the principles of histopathology, biochemical and radiological diagnosis as well as therapeutic options.

From the Department of Endocrine Oncology, University Hospital, Uppsala (K. Öberg), Department of Medicine V, Hepatology and Gastroenterology, Aarhus University Hospital, Denmark (L. Astrup), Department of Endocrine Oncology, University Hospital, Uppsala (B. Eriksson), Morphology/Pathology Unit, St Olav's University Hospital, Department of Laboratory Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim (S.E. Falkmer), Cancer Clinic at St Olav's University Hospital, Section of Clinical Oncology, Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim (U.G. Falkmer), Department of Surgery C, Rigshospitalet, University of Copenhagen, Denmark (J. Gustafsen), Department of Surgery, Helsinki University Central Hospital, Finland (C. Haglund), Department of Surgery C, Rigshospitalet, University of Copenhagen, Denmark (U. Knigge), Department of Gastroenterology, Rikshospitalet Oslo, Norway (M.H. Vatn), Division of Endocrinology, Department of Medicine, Helsinki University Central Hospital, Finland (M. Välimäki)

From the Department of Endocrine Oncology, University Hospital, Uppsala (K. Öberg), Department of Medicine V, Hepatology and Gastroenterology, Aarhus University Hospital, Denmark (L. Astrup), Department of Endocrine Oncology, University Hospital, Uppsala (B. Eriksson), Morphology/Pathology Unit, St Olav's University Hospital, Department of Laboratory Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim (S.E. Falkmer), Cancer Clinic at St Olav's University Hospital, Section of Clinical Oncology, Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim (U.G. Falkmer), Department of Surgery C, Rigshospitalet, University of Copenhagen, Denmark (J. Gustafsen), Department of Surgery, Helsinki University Central Hospital, Finland (C. Haglund), Department of Surgery C, Rigshospitalet, University of Copenhagen, Denmark (U. Knigge), Department of Gastroenterology, Rikshospitalet Oslo, Norway (M.H. Vatn), Division of Endocrinology, Department of Medicine, Helsinki University Central Hospital, Finland (M. Välimäki)